Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC early clinical trials group
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (8) , 1061-1064
- https://doi.org/10.1016/0959-8049(94)90456-1
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Chemotherapy in metastatic melanomaMelanoma Research, 1995
- Preclinical activity of taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: Comparison with taxol and conventional antineoplastic agentsEuropean Journal Of Cancer, 1993
- Coping with toxicities of docetaxel (TaxotereTM)Annals of Oncology, 1993
- Antitumor activity of taxotere (RP 56976, NSC 628503), a new taxol analog, in experimental ovarian cancerAnnals of Oncology, 1993
- Chemotherapy for advanced malignant melanomaInternational Journal of Clinical and Laboratory Research, 1992
- Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of TaxolJNCI Journal of the National Cancer Institute, 1991